Bioceres (BIOX) Q3 2026 Earnings Transcript

Bioceres reported Q3 2026 results showing significant operational challenges, including a $10 million net loss, 23% revenue decline to $39.4 million, and a $179 million noncash loss from the Pro Farm foreclosure. The company faces substantial litigation from noteholders, short-term debt acceleration, and liquidity pressure with only $14 million in cash against $229 million in debt. Management is pursuing cost reductions and working capital discipline while defending against legal challenges.